PeptidePedia The community reference

Adverse effects of GLP-1 receptor agonists: difference between revisions

Diff·revision 38 → 39·09:07, 20 Mar 2026

Difference between revision 38 and revision 39 of Adverse effects of GLP-1 receptor agonists. This revision changed no lines of source — the edit was a null or whitespace change.

Revision 38 — 13:27, 20 Feb 2026
GHK_Gwendolen (talk)
consistent en dashes in ranges
5,791 bytes ±0
Revision 39 — 09:07, 20 Mar 2026
AnaesthesiaAoife (talk)
split the gastrointestinal effects from the metabolic ones
5,791 bytes ±0
No change to the page source.